December 2020

The newly formed Professional Practice and Social Implications (PPSI) Committee met early this year to create their Action Plan. This committee, established by the ASHG Board of Directors in 2019, is charged with helping ASHG members and the research community advance genetics and genomics in ways that integrate and embed societal impacts within research goals and practices.  This Action Plan, to be implemented over the next three to five... Read More

ASHG envisions a future with an informed public that continues to understand basic genetic concepts, receives equitable access to genetic information, and understands and appreciates humanity’s diversity. To achieve this, the Society has exhibited at a few 2020 conferences for the science-interested public and science educators. The goal of attending these conferences was to increase awareness of ASHG and its resources, as well as connect with a larger public community.   During the month of... Read More

Federal laws and policies have a major influence on genetics and genomics research and translation to advances in the clinic and the broader society. It is therefore imperative for ASHG to have a strong voice in how such laws and policies are developed and implemented. Recognizing this, the Society’s public policy and advocacy agenda has... Read More

ASHG Board Roundup from Fall Meeting  At its annual Fall meeting Oct. 25-26, ASHG’s Board of Directors focused on near-term outlooks and actions as it navigates the organization through the pandemic while remaining focused on serving members in a time of great need.  It also reviewed several new projects and activities. Prior to the meeting,... Read More

Published: Thursday, December 10, 2020, 10:00 a.m. U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org ROCKVILLE, Md. – The American Society of Human Genetics (ASHG) is pleased to announce a new partnership with GlaxoSmithKline (GSK) to promote greater diversity and inclusion in the human genetics and genomics research community. GSK joins the National Human Genome Research Institute... Read More